Biology of Reproduction, Vol 57, 1490-1494, Copyright © 1997 by Society for the Study of Reproduction

ARTICLES

Measurement of inhibin and activin in early human pregnancy: demonstration of fetoplacental origin and role in prediction of early- pregnancy outcome

GM Lockwood, WL Ledger, DH Barlow, NP Groome and S Muttukrishna
Nuffield Department of Obstetrics and Gynaecology, University of Oxford, United Kingdom. gillian.lockwood@obstetrics- gynaecology.oxford.ac.uk

To determine the source of the dimeric glycoproteins inhibin A (alpha- betaA) and activin A (betaA-betaA) in early pregnancy, we analyzed serial blood samples from women who became pregnant following in vitro fertilization (IVF) with fresh embryo transfer (ET; n = 52) and from women who achieved pregnancy with frozen-thawed embryos (n = 8). Elevated serum levels of inhibin A were detected in ongoing pregnancies from 4 wk gestation (13 days following ET) and increased to an initial peak at 9-10 wk gestation. Significantly higher levels (p < 0.05) were found in the multiple pregnancies, and nonviable clinical pregnancies had very low levels of inhibin A. Total activin A was detectable 14 days after ET (positive pregnancy test), and higher levels were associated with multiple gestations while rapidly falling levels heralded embryonic demise. The fetoplacental unit is thus confirmed as the major source of these glycoproteins. Inhibin pro-alphaC, which circulates in great excess as a functionally inactive monomer and as part of high molecular weight functional dimers, was detectable at levels above normal late-luteal values in singleton and multiple IVF arising from fresh ETs. With frozen-thawed embryo pregnancies, the levels of pro-alphaC-containing inhibins were extremely low, confirming that the corpus luteum of pregnancy is the major source of the alpha monomer. The initially low levels and very rapid decline in inhibin A in pregnancies with embryonic failure suggest a role for this glycoprotein as a monitor of early-pregnancy viability.

This article has been cited by other articles:

				R. L Jones, T. J Kaitu'u-Lino, G. Nie, L G. Sanchez-Partida, J. K Findlay, and L. A Salamonsen Complex expression patterns support potential roles for maternally derived activins in the establishment of pregnancy in mouse. Reproduction, November 1, 2006; 132(5): 799 - 810. [Abstract] [Full Text] [PDF]

				J. Elson, A. Tailor, R. Salim, K. Hillaby, T. Dew, and D. Jurkovic Expectant management of miscarriage--prediction of outcome using ultrasound and novel biochemical markers Hum. Reprod., August 1, 2005; 20(8): 2330 - 2333. [Abstract] [Full Text] [PDF]

				S. Luisi, P. Florio, F. M. Reis, and F. Petraglia Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy Hum. Reprod. Update, March 1, 2005; 11(2): 123 - 135. [Abstract] [Full Text] [PDF]

				A. Farina, N. Rizzo, M. Concu, I. Banzola, A. Sekizawa, S. Grotti, and P. Carinci Lower Maternal PLAC1 mRNA in Pregnancies Complicated with Vaginal Bleeding (Threatened Abortion <20 Weeks) and a Surviving Fetus Clin. Chem., January 1, 2005; 51(1): 224 - 227. [Full Text] [PDF]

				S. Muttukrishna, C. Bearfield, J. Johns, and E. Jauniaux Inhibin, activin, follistatin, activin receptors and {beta}-glycan gene expression in the villous tissue of miscarriage patients Mol. Hum. Reprod., November 1, 2004; 10(11): 793 - 798. [Abstract] [Full Text] [PDF]

				S. Tong, L. Rombauts, A. Mulder, B. Marjono, J. L. Onwude, and E. M. Wallace Increased Day 15-17 Serum Pro-{alpha}C Inhibin Levels Specific to Successful Pregnancy J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4464 - 4468. [Abstract] [Full Text] [PDF]

				S. Lahiri, C.J. Anobile, P. Stewart, and W.L. Ledger Changes in circulating concentrations of inhibins A and pro-{alpha} C during first trimester medical termination of pregnancy Hum. Reprod., April 1, 2003; 18(4): 744 - 748. [Abstract] [Full Text] [PDF]

				S. Muttukrishna, E. Jauniaux, N. Greenwold, H. McGarrigle, S. Jivraj, S. Carter, S. Elgaddal, N. Groome, and L. Regan Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages Hum. Reprod., December 1, 2002; 17(12): 3072 - 3078. [Abstract] [Full Text] [PDF]

				C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF]

				P. Thirunavukarasu, T. Stephenson, J. Forray, P. G. Stanton, N. Groome, E. Wallace, and D. M. Robertson Changes in Molecular Weight Forms of Inhibin A and Pro-{alpha}C in Maternal Serum during Human Pregnancy J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5794 - 5804. [Abstract] [Full Text] [PDF]

				C. Treetampinich, A. E. O'Connor, V. MacLachlan, N. P. Groome, and D. M. de Kretser Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome Hum. Reprod., September 1, 2000; 15(9): 2028 - 2032. [Abstract] [Full Text] [PDF]

				A.E. O'Connor, J.R. McFarlane, S. Hayward, T. Yohkaichiya, N.P. Groome, and D.M. de Kretser Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study Hum. Reprod., March 1, 1999; 14(3): 827 - 832. [Abstract] [Full Text] [PDF]